Anxiety Disorders

Anxiety disorders - in Brief

While occasional fears and worries are a normal part of life, anxiety becomes a disorder when it is unfounded, excessively intense, or persistent. Anxiety disorders are a group of mental health conditions characterized by excessive fear, worry, or nervousness that interferes with daily life. These disorders often involve persistent, irrational anxiety disproportionate to any actual threat and can cause significant distress or impairment in social, occupational, or other important areas of functioning.

Anxiety disorders are the most common mental health challenges worldwide. Nearly one in four people experiences an anxiety disorder at least once in their lifetime. Symptoms typically begin in adolescence or in early adulthood, however they can occur at any age. Risk for anxiety disorders include genetic predisposition, environmental factors, brain chemistry and personality traits. They are often associated with other mental health conditions. Anxiety disorders frequently occur along with other conditions such as depression, bipolar disorder, substance use disorder, post-traumatic stress disorder (PTSD) and chronic medical diseases. Anxiety disorders can also increase the risk of suicidal thoughts, suicide attempts and self-harm.

Before beginning therapy, it is important to identify the specific sub-set of anxiety via a comprehensive diagnostic process including specific neuropsychological testing to avoid any incorrect diagnosis and treatment. At JB private mental health, we offer exactly this comprehensive diagnostic process and provide our clients with specific treatment recommendations and support.

Mild anxiety disorder cases often improve with professional psychoeducation and guidance as well as lifestyle changes such as exercise and relaxation techniques. Moderate to severe cases respond well to evidence-based psychotherapy – particularly Cognitive Behavioural Therapy (CBT) – often combined with anti-anxiety medications such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) when necessary to enhance therapy outcomes. Further psychotherapeutic treatment options include Acceptance and Commitment Therapy (ACT), Dialectic Behavioural Therapy (DBT), Mindfulness-Based Stress Reduction (MBSR), Eye Movement Desensitization and Reprocessing (EMDR), and Psychodynamic Psychotherapy. Novel advancements in neuroscience and therapy research also point to the promise of non-invasive brain stimulation techniques like Transcranial Direct Current Stimulation (tDCS) and repetitive Transcranial Magnetic Stimulation (rTMS).

Effective therapy and treatment strategies should always be highly individualized, aiming to reduce the severity of the symptoms as quickly as possible and maintain therapy motivation through early positive reinforcement.

Types of Anxiety Disorders

Generalized Anxiety Disorder (GAD) involves chronic, excessive worry about various aspects of life, including health, work, finances or relationships.

Panic Disorder is defined by recurring, unexpected panic attacks. These attacks involve sudden episodes of intense fear or discomfort, often accompanied by physical symptoms like heart palpitations, sweating, and shortness of breath.

Social Anxiety Disorder (Social Phobia) is marked by an intense persistent fear of social situations where one may feel embarrassed, humiliated, or rejected.

Specific Phobias are intense and irrational fears of specific objects or situations that lead to avoidance behaviour and significant distress.

Agoraphobia is a fear of situations where escape might be difficult, such as crowded or open spaces.

Selective Mutism is a rare disorder in which a person, typically a child, consistently fails to speak in certain social situations despite being able to speak in others.

Mixed anxiety and depressive disorder involve an affected person exhibiting both anxiety and depressive symptoms, without one set of symptoms being dominant over the other.

Key Messages

  • Anxiety disorders can range from excessive general worry (GAD) to severe panic (panic disorder) and specific fears (phobias, social anxiety, agoraphobia).
  • They are caused by a combination of genetic, environmental, and brain chemistry factors.
  • Treatment options include psychotherapy (in particular CBT and Psychodynamic therapy), non-invasive stimulations techniques (repetitive Transcranial Magnetic Stimulation (rTMS) or transcranial Direct-Current Stimulation (tDCS)), medication (SSRIs, SNRIs), and lifestyle changes (exercise, relaxation techniques).

Symptoms​

Individuals with an anxiety disorder often experience a heightened sense of fear or worry in specific situations or, in the case of Generalized Anxiety Disorder (GAD), across a broad spectrum of everyday situations. This anxiety tends to occur in ways that are disproportionate to the actual level of threat, leading a person to feel anxious or endangered even in situations that are objectively safe.

Over time, many individuals develop avoidance behaviours, steering clear of situations that trigger their anxieties, which can further reinforce and intensify the condition.

The spectrum of symptoms may include:

  • Difficulty sleeping or relaxing
  • Feeling nervous, irritable, tense or restless
  • Excessive worrying
  • Nausea or abdominal distress
  • Shortness of breath
  • Arrhythmia or heart palpitations (feelings of having a fast beating, fluttering or pounding heart)
  • Sweating, trembling or shaking
  • Fainting or temporary loss of consciousness
  • Agitation or a feeling of impending doom
  • Difficulty concentrating or making everyday decisions

Causes & Risk Factors:

  • Genetic predisposition (including family history of anxiety)
  • Brain chemistry (imbalances in neurotransmitters like serotonin and dopamine)
  • Environmental factors (stress, trauma, severe medical conditions, adverse life experiences)
  • Personality traits (high neuroticism, introversion, conscientiousness)

Occasional fears and worries are a normal part of life and reflect an important capacity for human beings. Why these natural mechanisms manifest themselves as pathological, exaggerated anxiety in some individuals has not yet been fully clarified. However, multifactorial triggers and risk factors are being widely discussed. A genetic predisposition may increase susceptibility, while negative learning experiences can heighten fears. Stressful or traumatic life events, interpersonal conflicts, severe medical conditions or impending losses can increase and shape symptoms.

 

In some cases, specific triggers like crowds or social situations can be clearly identified. On others, anxiety can occur without any clear cause. Unhelpful coping strategies, such as avoidance behaviours or substance use, often reinforce and sustain excessive anxiety. Women suffer twice as often as men from anxiety disorders, and socioeconomic factors such as low income, low level of education, unemployment as well as repetitive aversive interpersonal experiences, are associated with increased risk and symptom severity.

Although comprehensive neurobiological studies have yet to identify reliable biomarkers for the detection of anxiety disorders, the proven effectiveness of medications that influence serotonin transmission in the brain suggests that this system plays a key role in the development of anxiety disorders.

Treatment Options

Effective and optimized treatment is highly individual and should evaluate previous treatment results, consider associated (comorbid) mental and physical conditions, and address psychological, physical and social dimensions. International guidelines recommend that mild anxiety disorders can often improve with professional education, structured self-help strategies, and exercises designed to confront anxious situations in real life. For moderate to severe cases, evidence supports a combination of psychotherapy and pharmacological interventions as the most effective approach.

  • Therapy: Cognitive-Behavioural Therapy (CBT) is the most effective psychotherapeutic treatment. Other evidence-based therapies include Metacognitive Therapy (MCT), Acceptance and Commitment Therapy (ACT), Dialectic Behavioural Therapy (DBT), Mindfulness-Based Stress Reduction (MBSR), Eye Movement Desensitization and Reprocessing (EMDR), and Psychodynamic Psychotherapy.
  • Medication: Approved pharmacological treatments for Panic Disorder, Generalized Anxiety Disorder, and Social Phobia include antidepressants (SSRIs and SNRIs), calcium-channel modulators and benzodiazepines (short-term use). Pregabalin, a calcium-channel modulator, has shown efficacy in treating Generalized Anxiety Disorder. Benzodiazepines may be described for short-term use in specific cases.
  • Lifestyle Changes: Regular physical activity, exercise, effective stress management techniques, meditation, and healthy sleep habits can support and enhance therapeutic outcomes.
  • Non-Invasive Brain Stimulation: Transcranial Direct-Current Stimulation (tDCS) and repetitive Transcranial Magnetic Stimulation (rTMS) are emerging techniques that modulate brain activity. These can be used as standalone treatments or integrated into a broader therapeutic plan alongside psychotherapy and medication.

An individualized treatment plan should be developed in collaboration with the patient and tailored to their preferences, severity of the disorder, the expected latency and durability of the treatment effect, the expected side effects, and the therapeutic setting (e.g., inpatient vs. outpatient care, time commitment, availability, motivation).

The strongest evidence for psychotherapeutic intervention continues to support Cognitive Behavioural Therapy (CBT). If CBT remains ineffective, a treatment with Psychodynamic Psychotherapy should be attempted. Further therapy forms include Dialectic Behavioural Therapy (DBT), Mindfulness-Based Stress Reduction (MBSR), Eye Movement Desensitization and Reprocessing (EMDR) and non-invasive stimulations techniques such as repetitive transcranial magnetic stimulation (rTMS) or transcranial Direct-Current Stimulation (tDCS).

When pharmacotherapy is pursued, prescribed medication should be based on the following factors: The person’s preference, the effectiveness of the medication for the specific anxiety disorder, the response to previous treatment methods, and potential side effects. These methods target brain activity and can be combined with psychotherapeutic interventions and medication. If the person shows progress with the medication, it is generally recommended to continue the medication for 6-12 months before re-evaluation and considering a gradual reduction in the dosage.

Effective and optimized treatment is highly individual and should evaluate previous treatment results, consider associated (comorbid) mental and physical conditions, and address psychological, physical and social dimensions. International guidelines recommend that mild anxiety disorders can often improve with professional education, structured self-help strategies, and exercises designed to confront anxious situations in real life. For moderate to severe cases, evidence supports a combination of psychotherapy and pharmacological interventions as the most effective approach.